NEWSROOM | Galderma

Cetaphil® Announces Partnership with Award-Winning Actress, Rachel Brosnahan

Launch of the Skin Science Foundation

Nestlé enters into exclusive negotiations to sell Nestlé Skin Health to a consortium led by EQT and ADIA

A Decade of Dysport®: Galderma Celebrates 10 Years Since FDA Approval of Dysport in the U.S.

Galderma marks Rosacea Awareness Month with new insights into why some patients are self-treating and launches social media campaign to reinforce hidden impact of the disease

Galderma´s Azzalure and Dysport® celebrate a decade of treatment of the glabellar lines

Nestlé Skin Health SHIELD Hosts Skin Microbiome Summit

Galderma Announces U.S. Collaboration with Nespresso®

Galderma Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting Late-Breaking Session

Galderma: New data reveals benefits of combining oral and topical treatment in patients with severe papulopustular rosacea

Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology

Galderma Announces Formation of Women in Aesthetics Leadership Council